Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Anondita Medicare Ltd

NSE: ANONDITA · FMCG · 59 announcements

Share price
₹1,075.00
Market cap
₹2,047 Cr
Revenue (annual)
₹137.4 Cr
Net profit (annual)
₹33.45 Cr
P/E (TTM)
61.2×Sector 42.5×
Promoter holding
59.26%
FII holding
2.48%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

20:49 IST NSE
Annual General Meeting

Anondita Medicare Annual General Meeting

Anondita Medicare Limited has issued the notice for its 3rd Annual General Meeting scheduled for September 29, 2026. The meeting will address ordinary and special business resolutions.

13:45 IST NSE
Annual General Meeting

Anondita Medicare Annual General Meeting

Anondita Medicare Limited announced the successful passing of seven resolutions at its EGM. Approved items include warrant issuance, related party transactions, and managerial remuneration increases.

14:55 IST NSE
Annual General Meeting

Anondita Medicare Annual General Meeting

Anondita Medicare issued a second corrigendum to its EGM notice regarding revised warrant pricing. The update reflects changes in valuation following a revised 90-day trading period calculation.

20:25 IST NSE
Annual General Meeting

Anondita Medicare Annual General Meeting

Anondita Medicare issued a corrigendum for its upcoming EGM regarding a ₹29.58 Crore preferential warrant issue. Key changes include revised relevant dates and updated valuation details.

Value
₹29.58 Cr
Execution
18 months
22:15 IST NSE
Annual General Meeting

Anondita Medicare Annual General Meeting

Anondita Medicare Limited convened an EGM for May 28, 2026, to approve ₹137.59 Crore in related party transactions and preferential warrant issuance to promoters.

Value
₹137.6 Cr
Execution
FY 2026-27
18:17 IST NSE
Annual General Meeting

Anondita Medicare Annual General Meeting

Anondita Medicare Limited has convened an EGM for May 28, 2026, to approve a ₹29.13 Crore preferential issue of convertible warrants to promoters. Other agenda items include material related party transactions and an increase in managerial remuneration for the Managing Director and Whole-Time Director.

Value
₹29.13 Cr
Execution
18 months